Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL.
Anderson DR, Gangaraju R, Sedhom WG, Hamulyák EN, Wang TF, O'Dwyer K, Carney BJ, Muthiah C, Liedtke M, Badar T, Shimony S, Robinson R, Sanfilippo K, Derkach A, Dinner S, Biemond BJ, Nemirovsky D, Goldberg LA, Kapadia AD, Levavi H, Bar-Natan M, Van Hyfte G, Bansal K, Carrier M, Fulcher J, Gerrits AM, Litzow MR, Luger S, Guru Murthy GS, Luskin M, Wolach O, Shomali W, Zwicker JI, Stock W, Leader A.
Anderson DR, et al. Among authors: nemirovsky d.
Blood Adv. 2026 Feb 10;10(3):593-603. doi: 10.1182/bloodadvances.2025017862.
Blood Adv. 2026.
PMID: 41170879
Free PMC article.